Bill Text: MN HF2487 | 2013-2014 | 88th Legislature | Introduced
Bill Title: Medical assistance coverage allowed for drugs and pharmaceutical ingredients used for weight loss.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2014-02-27 - Introduction and first reading, referred to Health and Human Services Policy [HF2487 Detail]
Download: Minnesota-2013-HF2487-Introduced.html
1.2relating to human services; allowing medical assistance coverage for drugs and
1.3pharmaceutical ingredients used for weight loss;amending Minnesota Statutes
1.42012, section 256B.0625, subdivision 13d.
1.5BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.6 Section 1. Minnesota Statutes 2012, section 256B.0625, subdivision 13d, is amended
1.7to read:
1.8 Subd. 13d. Drug formulary. (a) The commissioner shall establish a drug
1.9formulary. Its establishment and publication shall not be subject to the requirements of the
1.10Administrative Procedure Act, but the Formulary Committee shall review and comment
1.11on the formulary contents.
1.12 (b) The formulary shall not include:
1.13 (1) drugs, active pharmaceutical ingredients, or products for which there is no
1.14federal funding;
1.15 (2) over-the-counter drugs, except as provided in subdivision 13;
1.16(3) drugs or active pharmaceutical ingredients used for weight loss, except that
1.17medically necessary lipase inhibitors may be covered for a recipient with type II diabetes;
1.18(4) (3) drugs or active pharmaceutical ingredients when used for the treatment of
1.19impotence or erectile dysfunction;
1.20(5) (4) drugs or active pharmaceutical ingredients for which medical value has
1.21not been established; and
1.22(6) (5) drugs from manufacturers who have not signed a rebate agreement with
1.23the Department of Health and Human Services pursuant to section 1927 of title XIX of
1.24the Social Security Act.
2.1 (c) If a single-source drug used by at least two percent of the fee-for-service
2.2medical assistance recipients is removed from the formulary due to the failure of the
2.3manufacturer to sign a rebate agreement with the Department of Health and Human
2.4Services, the commissioner shall notify prescribing practitioners within 30 days of
2.5receiving notification from the Centers for Medicare and Medicaid Services (CMS) that a
2.6rebate agreement was not signed.
1.3pharmaceutical ingredients used for weight loss;amending Minnesota Statutes
1.42012, section 256B.0625, subdivision 13d.
1.5BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.6 Section 1. Minnesota Statutes 2012, section 256B.0625, subdivision 13d, is amended
1.7to read:
1.8 Subd. 13d. Drug formulary. (a) The commissioner shall establish a drug
1.9formulary. Its establishment and publication shall not be subject to the requirements of the
1.10Administrative Procedure Act, but the Formulary Committee shall review and comment
1.11on the formulary contents.
1.12 (b) The formulary shall not include:
1.13 (1) drugs, active pharmaceutical ingredients, or products for which there is no
1.14federal funding;
1.15 (2) over-the-counter drugs, except as provided in subdivision 13;
1.16
1.17
1.18
1.19impotence or erectile dysfunction;
1.20
1.21not been established; and
1.22
1.23the Department of Health and Human Services pursuant to section 1927 of title XIX of
1.24the Social Security Act.
2.1 (c) If a single-source drug used by at least two percent of the fee-for-service
2.2medical assistance recipients is removed from the formulary due to the failure of the
2.3manufacturer to sign a rebate agreement with the Department of Health and Human
2.4Services, the commissioner shall notify prescribing practitioners within 30 days of
2.5receiving notification from the Centers for Medicare and Medicaid Services (CMS) that a
2.6rebate agreement was not signed.
